Hims & Hers Health, Inc. (HIMS) Tops Q2 EPS by 5c, Revenue Guidance Beats
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Hims & Hers Health, Inc. Reports Second Quarter 2021 Financial Results
August 11, 2021 4:05 PM EDTQ2 2021 revenue grows 69% year-over-year to $60.7 million
Q2 2021 online revenue grows 75% year-over-year to $58.1 million
Exceeds Q2 2021 guidance, raises full year 2021 expectations
SAN FRANCISCO--(BUSINESS WIRE)-- Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, today reported financial results for the second quarter ending June 30, 2021.
"This was a quarter of very strong execution, as we continued to drive consistent organic revenue growth across our business, from our core... More
